Pharmaceutical Value proposition
New ways to care
Pierre Fabre Group held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise.
This makes Pierre Fabre Group :
đ A pharmaceutical group with a strong positioning : medical and natural
đ„ The second largest dermo-cosmetics laboratory in the world
đ„ The second largest private French pharmaceutical group
đ„ The market leader in France for products sold over the counter in pharmacies.
Our portfolio includes several medical franchises and international brands including ;
Pharmaceutical Care
Pierre Fabre Oncologie
Pierre Fabre Dermatologie
Naturactive
Eau Thermale AvĂšne
Klorane
Ducray
René Furterer
A-Derma
Pierre Fabre Oral Care
Glytone (US)
Darrow (Brasil)
Established in the Occitanie region since its creation, we manufacture over 95% of our products in France. We keep innovating passionately with our teams in 2 innovation centers in Brasil and Japan as well as in 6 R&D centers in France.
Thanks to our 9,600 employees in 44 subsidiaries and our distribution activities in 120 countries, our group generated âŹ2.7 billion in revenues in 2022, 69% of which is from international business.
Pierre Fabre Group has a unique company structure.
86% of the Pierre Fabre Group is held by the Pierre Fabre Foundation, a government-recognized public-interest foundation, while a smaller share is owned by its employees via an employee stock ownership plan.
In 2020, the independent organization ECOCERT Environment awarded Pierre Fabre's CSR policy at "excellence" level : - Excellence being the highest maturity level of the ECOCERT 26000 standard.
From Health to Beauty, Family Health, Dermo-Cosmetics, Pharmaceuticals, De la Santé à la Beauté, Dermo-Cosmétique, Médicaments, Santé Familiale, oncology, skincare, haircare, and personal careOriginal language
New ways to care
Pierre Fabre Group held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise.
This makes Pierre Fabre Group :
đ A pharmaceutical group with a strong positioning : medical and natural
đ„ The second largest dermo-cosmetics laboratory in the world
đ„ The second largest private French pharmaceutical group
đ„ The market leader in France for products sold over the counter in pharmacies.
Our portfolio includes several medical franchises and international brands including ;
Pharmaceutical Care
Pierre Fabre Oncologie
Pierre Fabre Dermatologie
Naturactive
Eau Thermale AvĂšne
Klorane
Ducray
René Furterer
A-Derma
Pierre Fabre Oral Care
Glytone (US)
Darrow (Brasil)
Established in the Occitanie region since its creation, we manufacture over 95% of our products in France. We keep innovating passionately with our teams in 2 innovation centers in Brasil and Japan as well as in 6 R&D centers in France.
Thanks to our 9,600 employees in 44 subsidiaries and our distribution activities in 120 countries, our group generated âŹ2.7 billion in revenues in 2022, 69% of which is from international business.
Pierre Fabre Group has a unique company structure.
86% of the Pierre Fabre Group is held by the Pierre Fabre Foundation, a government-recognized public-interest foundation, while a smaller share is owned by its employees via an employee stock ownership plan.
In 2020, the independent organization ECOCERT Environment awarded Pierre Fabre's CSR policy at "excellence" level : - Excellence being the highest maturity level of the ECOCERT 26000 standard.
Pierre Fabre | A French pharmaceutical and dermocosmetics group
Pierre Fabre | A French pharmaceutical and dermocosmetics group
https://www.pierre-fabre.com/en
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | La Fresque de l'Economie Circulaire cleantech | Other | ||
 | POLUX healthtech | Other | ||
 | AUSTRALIEGAD martech, Advertising Services | Other 10 Apr 2024 | | |
 | ClimatMĂ©dias Government Relations Services | Other 29 Feb 2024 | | |
 | PulseLife (ex 360 medics) healthtech, IT Services, IT Services and IT Consulting | Other 5 Apr 2024 | | |
 | IMS (Institut du MĂ©dicament de Strasbourg) deeptech | Other 12 Apr 2024 | | |
 | Petrel Commerce Circulaire greentech, cleantech, Renewable Energy Semiconductor Manufacturing | Other 29 Mar 2024 | | |
 | Jake - Agence digitale santé healthtech, Advertising Services | Other 29 Mar 2024 | | |
 | Agence Gardeners martech, Advertising Services | Other 9 Apr 2024 | | |
 | Fédération des Aveugles et Amblyopes de France healthtech, Civic and Social Organizations | Other 6 Apr 2024 | | |